{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:18:28Z","timestamp":1788185908136,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K11566"],"award-info":[{"award-number":["JP24K11566"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19ek0510023h0003"],"award-info":[{"award-number":["19ek0510023h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12185-026-04223-0","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:44:54Z","timestamp":1777905894000},"page":"399-412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in Japan: changes in practice patterns and outcomes during the past 20\u00a0years"],"prefix":"10.1007","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1602-9775","authenticated-orcid":false,"given":"Masamitsu","family":"Yanada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimitsu","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Onizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Kawakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Konuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"4223_CR1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813\u201326.","journal-title":"N Engl J Med"},{"key":"4223_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","volume":"124","author":"B Gyurkocza","year":"2014","unstructured":"Gyurkocza B, Sandmaier BM. Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. Blood. 2014;124:344\u201353.","journal-title":"Blood"},{"key":"4223_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1182\/blood-2014-02-514760","volume":"124","author":"N Kekre","year":"2014","unstructured":"Kekre N, Antin JH. Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist. Blood. 2014;124:334\u201343.","journal-title":"Blood"},{"key":"4223_CR4","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.3324\/haematol.2019.245688","volume":"105","author":"N Granot","year":"2020","unstructured":"Granot N, Storb R. History of hematopoietic cell transplantation: challenges and progress. Haematologica. 2020;105:2716\u201329.","journal-title":"Haematologica"},{"key":"4223_CR5","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0140-6736(11)60828-3","volume":"378","author":"N Ikegami","year":"2011","unstructured":"Ikegami N, Yoo B-K, Hashimoto H, Matsumoto M, Ogata H, Babazono A, et al. Japanese universal health coverage: evolution, achievements, and challenges. Lancet. 2011;378:1106\u201315.","journal-title":"Lancet"},{"key":"4223_CR6","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s00277-020-04051-0","volume":"99","author":"M Yanada","year":"2020","unstructured":"Yanada M, Takami A, Yamasaki S, Arai Y, Konuma T, Uchida N, et al. Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century. Ann Hematol. 2020;99:1351\u201360.","journal-title":"Ann Hematol"},{"key":"4223_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","volume":"103","author":"Y Atsuta","year":"2016","unstructured":"Atsuta Y. Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data). Int J Hematol. 2016;103:3\u201310.","journal-title":"Int J Hematol"},{"key":"4223_CR8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H Dohner","year":"2022","unstructured":"Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345\u201377.","journal-title":"Blood"},{"key":"4223_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649\u201355.","journal-title":"Am J Clin Oncol"},{"key":"4223_CR10","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912\u20139.","journal-title":"Blood"},{"key":"4223_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/10428194.2017.1357173","volume":"59","author":"M Yanada","year":"2018","unstructured":"Yanada M, Mori J, Aoki J, Harada K, Mizuno S, Uchida N, et al. Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients. Leuk Lymphoma. 2018;59:601\u20139.","journal-title":"Leuk Lymphoma"},{"key":"4223_CR12","doi-asserted-by":"publisher","first-page":"1050633","DOI":"10.3389\/fonc.2022.1050633","volume":"12","author":"M Yanada","year":"2022","unstructured":"Yanada M, Harada K, Shimomura Y, Arai Y, Konuma T. Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: real-world data from the Japanese registry studies. Front Oncol. 2022;12:1050633.","journal-title":"Front Oncol"},{"key":"4223_CR13","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jtct.2021.04.007","volume":"27","author":"MA Kharfan-Dabaja","year":"2021","unstructured":"Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, et al. Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the american society for transplantation and cellular therapy. Transplant Cell Ther. 2021;27:642\u20139.","journal-title":"Transplant Cell Ther"},{"key":"4223_CR14","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transpl. 1995;15:825\u20138"},{"key":"4223_CR15","first-page":"250","volume":"28","author":"KM Sullivan","year":"1991","unstructured":"Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991;28:250\u20139.","journal-title":"Semin Hematol"},{"key":"4223_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/1536867X0900900206","volume":"9","author":"PC Lambert","year":"2009","unstructured":"Lambert PC, Royston P. Further development of flexible parametric models for survival analysis. Stata J. 2009;9:265\u201390.","journal-title":"Stata J"},{"key":"4223_CR17","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1200\/JCO.1985.3.10.1418","volume":"3","author":"RJ Simes","year":"1985","unstructured":"Simes RJ, Zelen M. Exploratory data analysis and the use of the hazard function for interpreting survival data: an investigator\u2019s primer. J Clin Oncol. 1985;3:1418\u201331.","journal-title":"J Clin Oncol"},{"key":"4223_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12185-023-03677-w","volume":"119","author":"K Usuki","year":"2024","unstructured":"Usuki K, Ohtake S, Honda S, Matsuda M, Wakita A, Nawa Y, et al. Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11). Int J Hematol. 2024;119:24\u201338.","journal-title":"Int J Hematol"},{"key":"4223_CR19","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","volume":"26","author":"A D'Souza","year":"2020","unstructured":"D\u2019Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, et al. Current use of and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant. 2020;26:e177\u201382.","journal-title":"Biol Blood Marrow Transplant"},{"key":"4223_CR20","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","volume":"56","author":"JR Passweg","year":"2021","unstructured":"Passweg JR, Baldomero H, Chabannon C, Basak GW, de la Camara R, Corbacioglu S, et al. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transplant. 2021;56:1651\u201364.","journal-title":"Bone Marrow Transplant"},{"key":"4223_CR21","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1038\/s41409-019-0539-8","volume":"54","author":"M Yanada","year":"2019","unstructured":"Yanada M, Konuma T, Kuwatsuka Y, Kondo T, Kawata T, Takahashi S, et al. Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience. Bone Marrow Transplant. 2019;54:1789\u201398.","journal-title":"Bone Marrow Transplant"},{"key":"4223_CR22","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1007\/s00277-024-05944-0","volume":"103","author":"J Sugita","year":"2024","unstructured":"Sugita J, Morita K, Konuma T, Yanada M. Allogeneic hematopoietic cell transplantation from alternative donors in acute myeloid leukemia. Ann Hematol. 2024;103:4851\u201368.","journal-title":"Ann Hematol"},{"key":"4223_CR23","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.bbmt.2011.05.001","volume":"17","author":"M Remberger","year":"2011","unstructured":"Remberger M, Ackefors M, Berglund S, Blennow O, Dahllof G, Dlugosz A, et al. Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. a single-center study. Biol Blood Marrow Transplant. 2011;17:1688\u201397.","journal-title":"Biol Blood Marrow Transplant"},{"key":"4223_CR24","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1200\/JCO.2010.32.5001","volume":"29","author":"JT Horan","year":"2011","unstructured":"Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, et al. Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? J Clin Oncol. 2011;29:805\u201313.","journal-title":"J Clin Oncol"},{"key":"4223_CR25","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/bmt.2013.42","volume":"48","author":"S Kurosawa","year":"2013","unstructured":"Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H, et al. Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia. Bone Marrow Transplant. 2013;48:1198\u2013204.","journal-title":"Bone Marrow Transplant"},{"key":"4223_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bbmt.2014.10.001","volume":"21","author":"NS Majhail","year":"2015","unstructured":"Majhail NS, Chitphakdithai P, Logan B, King R, Devine S, Rossmann SN, et al. Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era. Biol Blood Marrow Transplant. 2015;21:142\u201350.","journal-title":"Biol Blood Marrow Transplant"},{"key":"4223_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/joim.12854","volume":"285","author":"J Canaani","year":"2019","unstructured":"Canaani J, Beohou E, Labopin M, Ghavamzadeh A, Beelen D, Hamladji RM, et al. Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP\/EBMT analysis. J Intern Med. 2019;285:407\u201318.","journal-title":"J Intern Med"},{"key":"4223_CR28","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41409-018-0301-7","volume":"54","author":"M Yanada","year":"2019","unstructured":"Yanada M, Masuko M, Mori J, Aoki J, Mizuno S, Fukuda T, et al. Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades. Bone Marrow Transplant. 2019;54:578\u201386.","journal-title":"Bone Marrow Transplant"},{"key":"4223_CR29","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1016\/S2352-3026(19)30158-9","volume":"6","author":"R Shouval","year":"2019","unstructured":"Shouval R, Fein JA, Labopin M, Kroger N, Duarte RF, Bader P, et al. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European society for blood and marrow transplantation registry retrospective analysis. Lancet Haematol. 2019;6:e573\u201384.","journal-title":"Lancet Haematol"},{"key":"4223_CR30","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1111\/bjh.18511","volume":"200","author":"LK Gjaerde","year":"2023","unstructured":"Gjaerde LK, Jakobsen LH, Juhl-Christensen C, Olesen G, Petruskevicius I, Severinsen MT, et al. Trends in survival and cure after allogeneic haematopoietic cell transplantation for acute myeloid leukaemia from 2000 to 2020: a Danish population-based cohort study. Br J Haematol. 2023;200:e40\u20133.","journal-title":"Br J Haematol"},{"key":"4223_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1445-5994.2010.02262.x","volume":"41","author":"I Nivison-Smith","year":"2011","unstructured":"Nivison-Smith I, Dodds AJ, Dunckley H, Ma DD, Moore JJ, Simpson JM, et al. Increased activity and improved outcome in unrelated donor haemopoietic cell transplants for acute myeloid leukaemia in Australia, 1992-2005. Intern Med J. 2011;41:27\u201334.","journal-title":"Intern Med J"},{"key":"4223_CR32","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","volume":"363","author":"TA Gooley","year":"2010","unstructured":"Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363:2091\u2013101.","journal-title":"N Engl J Med"},{"key":"4223_CR33","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1182\/bloodadvances.2020003418","volume":"4","author":"O Penack","year":"2020","unstructured":"Penack O, Peczynski C, Mohty M, Yakoub-Agha I, Styczynski J, Montoto S, et al. How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT. Blood Adv. 2020;4:6283\u201390.","journal-title":"Blood Adv"},{"key":"4223_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.7326\/M19-2936","volume":"172","author":"GB McDonald","year":"2020","unstructured":"McDonald GB, Sandmaier BM, Mielcarek M, Sorror M, Pergam SA, Cheng GS, et al. Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003-2007 versus 2013-2017 cohorts. Ann Intern Med. 2020;172:229\u201339.","journal-title":"Ann Intern Med"},{"key":"4223_CR35","first-page":"1998","volume":"110","author":"HT Kim","year":"2025","unstructured":"Kim HT, Soiffer RJ, Cutler C, Koreth J, Nikiforow S, Shapiro RM, et al. Reduced incidence of relapse and graft-versus-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation. Haematologica. 2025;110:1998\u20132008.","journal-title":"Haematologica"},{"key":"4223_CR36","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41409-025-02573-7","volume":"60","author":"T Shimizu","year":"2025","unstructured":"Shimizu T, Arai Y, Kondo T, Yano S, Shimomura Y, Doki N, et al. Improved post-transplant outcomes for elderly acute myeloid leukemia patients conditioned with FLU\/BU4 rather than conventional MAC regimens. Bone Marrow Transplant. 2025;60:804\u201310.","journal-title":"Bone Marrow Transplant"},{"key":"4223_CR37","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/s41409-020-01163-z","volume":"56","author":"M Yanada","year":"2021","unstructured":"Yanada M, Konuma T, Yamasaki S, Kondo T, Fukuda T, Shingai N, et al. Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes. Bone Marrow Transplant. 2021;56:1126\u201333.","journal-title":"Bone Marrow Transplant"},{"key":"4223_CR38","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1182\/bloodadvances.2024012722","volume":"8","author":"PA Carpenter","year":"2024","unstructured":"Carpenter PA, Gooley TA, Boiko J, Lee CJ, Burroughs LM, Mehta R, et al. Decreasing chronic graft-versus-host disease rates in all populations. Blood Adv. 2024;8:5829\u201337.","journal-title":"Blood Adv"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04223-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04223-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04223-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:56:21Z","timestamp":1788184581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04223-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4223"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04223-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Nagoya City University Institutional Review Board. All methods were performed in accordance with the Declaration of Helsinki, and all patients provided informed consent for the utilization of their clinical data for research.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}